Market Tracker

04/28 3:50pm ET
26.92
BATS BZX Real-Time Price
As of 3:50pm ET
 -0.07 / -0.26%
Today’s Change
20.07
Today|||52-Week Range
42.48
-4.84%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close26.99
Today’s open27.20
Day’s range26.75 - 27.47
Volume5,688
Average volume (3 months)334,092
Market cap$893.3M
Dividend yield--
Data as of 3:50pm ET, 04/28/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+68.75%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio96.7
Price/Sales11.37
Price/Book7.24

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...+0.08+1.18%
ADROAduro Biotech Inc+0.05+0.37%
TBPHTheravance Biopharma...-2.45-10.37%
SUPNSupernus Pharmaceuti...+0.04+0.23%
Data as of 3:50pm ET, 04/28/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts